Concepedia

Alisha Holtzhausen

AH

Statistics

Publications

17

Citations

2K

H-Index

16

Active since

2011

Affiliations

Duke Medical Center(Current)

University of North Carolina at Chapel Hill

Duke University

Duke University Hospital

UNC Lineberger Comprehensive Cancer Center

Alisha Holtzhausen is an author at Duke Medical Center specializing in oncology, immunology, and cancer immunotherapy.

ORCID

Publications per year

2011–2024

17

Publications

17

Paracrine Wnt5a-β-Catenin Signaling Triggers a Metabolic Program that Drives Dendritic Cell Tolerization

Fei Zhao, Christine Xiao, Kathy S. Evans et al. · Immunity · 2018 · 297 citations · Full text

, , +16

A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti–PD-1 immunotherapy

Balamayoora Theivanthiran, Kathy S. Evans, Nicholas C. DeVito et al. · Journal of Clinical Investigation · 2020 · 250 citations · Full text

, , +17

Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune response

Eric Ubil, Laura S. Caskey, Alisha Holtzhausen et al. · Journal of Clinical Investigation · 2018 · 213 citations · Full text

, , +17

Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy

Alisha Holtzhausen, Fei Zhao, Kathy S. Evans et al. · Cancer Immunology Research · 2015 · 179 citations · Full text

, , +17

Novel bone morphogenetic protein signaling through Smad2 and Smad3 to regulate cancer progression and development

Alisha Holtzhausen, Christelle Golzio, Tam How et al. · The FASEB Journal · 2013 · 129 citations

, , +15

1–5 of 17